Skip to main content
Premium Trial:

Request an Annual Quote

Illumina to Market GenoLogics' Geneus LIMS

Premium

GenoLogics said this week that Illumina will market a version of its Geneus Laboratory Information Management System software that is preconfigured to handle data from Illumina's HiSeq and Genome Analyzer sequencing platforms and TruSeq sample preparation kits.

The Canadian firm said that its software will enable Illumina users to automate workflows, track library preparations and instrument runs, and prepare basic reports within weeks rather than months.

GenoLogics CEO Michael Ball noted that the combined efforts of the two firms will enable sequencing laboratories to deploy instrumentation and data management tools simultaneously, thus addressing a data-related bottleneck highlighted in a recent survey conducted by JP Morgan.

GenoLogics noted that 63 percent of NGS laboratory directors who participated in the survey identified data storage, data management, and informatics as the "biggest hurdles to expanding next-generation sequencing."

Ball noted that the current arrangement follows an earlier preferred partner agreement between the two companies that made it possible for his firm to develop a version of the LIMS software that is "complementary" to Illumina's sequencing platforms and sample prep kits.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.